FDA advisory panel backs over-the-counter birth control

 Axios - An FDA advisory panel today unanimously endorsed making daily birth control pills available over-the-counter for the first time, Axios' Oriana Gonzalez reports. If the FDA follows the recommendation and switches HRA Pharma's Opill away from prescription-only use, it could expand the availability of contraception — and deepen partisan rifts over reproductive health in the post-Roe landscape.. . . . Reproductive rights advocates say that allowing for the over-the-counter sale of birth control pills could increase access to the 19 million women living in contraceptive deserts.